BIGG

Resultados: 80

WHO policy on collaborative TB/HIV activities: guidelines for national programmes and other stakeholders

In 2004, the World Health Organization (WHO) published an interim policy on collaborative TB/HIV activities in response to demand from countries for immediate guidance on actions to decrease the dual burden of tuberculosis (TB) and human immunodeficiency virus (HIV). The term interim was used because the...

Guidance on oral pre-exposure prophylaxis (PrEP) for serodiscordant couples, men and transgender women who have sex with men at high risk of HIV

These recommendations have been developed specifically to address the daily use of antiretrovirals in HIV-uninfected people to block the acquisition of HIV infection. This prevention approach is known as pre-exposure prophylaxis. At this stage evidence is available from studies with two groups: men and t...

Guidance on couples HIV testing and counselling: including antiretroviral therapy for treatment and prevention in serodiscordant couples

This WHO guidelines recommend offering HIV testing and counselling to couples, wherever HIV testing and counselling is available, including in antenatal clinics. For couples where only one partner is HIV positive, the guidelines recommend offering antiretroviral therapy to the HIV positive partner, regar...

Hormonal contraception and HIV: technical statement

Following new findings from recently published epidemiological studies, the World Health Organization (WHO) convened a technical consultation regarding hormonal contraception and HIV acquisition, progression and transmission. It was recognized that this issue was likely to be of particular concern in cou...

Guidelines:prevention and treatment of HIV and other sexually transmitted infections among men who have sex with men and transgender people: recommendations for a public health approach 2011

Since the beginning of the epidemic in the early 1980s, men who have sex with men (MSM) and transgender people have been disproportionately affected by the human immunodeficiency virus (HIV). The risk for infection remains high among them; and there has been a resurgence of HIV infection among MSM, parti...

Guideline: Vitamin A supplementation in pregnancy for reducing the risk of mother-to-child transmission of HIV

Over 1000 new cases of mother-to-child transmission of the human immunodeficiency virus (HIV) occur worldwide every day, making this the main route of transmission of HIV infection in children. Vitamin A deficiency affects about 19 million pregnant women, mostly from the WHO regions of Africa and South-E...

Guideline on HIV disclosure counselling for children up to 12 years of age

The World Health Organization (WHO) has developed guidance for health care workers on how to support children up to 12 years of age and their caregivers with disclosure of HIV status. Health care workers (HCWs) know that disclosure decisions are complex because of stigma, social support concerns, family ...

Manual on paediatric HIV care and treatment for district hospitals: addendum to the Pocket book of hospital care of children

HIV is increasingly affecting the health and welfare of children and undermining hard-won gains in child survival in some of the highly affected countries. Recent estimates from UNAIDS suggest that, globally, about 2.1 million children younger than 15 years of age have HIV. The roll out of paediatric HIV...

Guidelines for the programmatic management of drug-resistant tuberculosis – 2011 update

This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response to the Sixty-second World Health Assembly’s resolution on prevention and control of multidrug-resistant tuberculosis and extensi...

Policy statement: automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system

Earlier and improved tuberculosis (TB) case detection - including smear-negative disease, often associated with HIV co-infection - as well as expanded capacity to diagnose multidrug-resistant tuberculosis (MDR-TB) are global priorities for TB control. Conventional laboratory methods are slow and cumberso...